KR880007084A - 제약 조성물 - Google Patents

제약 조성물 Download PDF

Info

Publication number
KR880007084A
KR880007084A KR870014856A KR870014856A KR880007084A KR 880007084 A KR880007084 A KR 880007084A KR 870014856 A KR870014856 A KR 870014856A KR 870014856 A KR870014856 A KR 870014856A KR 880007084 A KR880007084 A KR 880007084A
Authority
KR
South Korea
Prior art keywords
pharmaceutical composition
disease
fluticasone propionate
treatment
composition
Prior art date
Application number
KR870014856A
Other languages
English (en)
Inventor
안토니 리카르즈 데이비드
Original Assignee
원본미기재
글락소 그룹 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 원본미기재, 글락소 그룹 리미티드 filed Critical 원본미기재
Publication of KR880007084A publication Critical patent/KR880007084A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

내용 없음.

Description

제약 조성물
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (9)

  1. 부신당성피질성 스테로이드를 사용하는 치료에 응답하는 장 질환의 경구, 소구 또는 직장내 방식에 의한 치료에 사용하기 위해 플루티카손 프로피오네이트로 되는 것을 특징으로 하는 제약 조성물.
  2. 제1항에 있어서, 궤양성 대장염, 크론병 또는 소아지방변증의 치료에 사용하기 위한 제약 조성물.
  3. 제1항 또는 2항에 있어서, 서방형, 지연 방출형 또는 일정 위치에서 방출하는 형태인 것을 특징으로 하는 조성물.
  4. 제3항에 있어서, 장용피를 갖는 것을 특징으로 하는 조성물.
  5. 장용피를 갖는 것을 특징으로 하는 정제 또는 캡슐제 형태 중의 플루티카손 프로피오네이트로 되는 제약 조성물.
  6. 부산 당성피질성 스테로이드를 사용하는 치료에 응답하는 장 질환의 경구, 소구 또는 직장내 방식에 의한 치료용 제약 조성물의 제조에 있어서 플루티카손 프로피오네이트의 용도.
  7. 제6항에 있어서, 장 질환이 궤양성 대장염, 크론병 또는 소아지방변증인 것을 특징으로 하는 플루티카손 프로피오네이트의 용도.
  8. 제6항 또는 7항에 있어서, 제약 조성물이 지연 방출형, 서방형 또는 일정 위치에서 방출하는 형태인 것을 특징으로 하는 플루티카손 프로피오네이트의 용도.
  9. 제8항에 있어서, 제약 조성물이 장용피를 갖는 것을 특징으로 하는 플루피카손 프로피오네이트의 용도.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR870014856A 1986-12-24 1987-12-24 제약 조성물 KR880007084A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB868630913A GB8630913D0 (en) 1986-12-24 1986-12-24 Pharmaceutical compositions
GB8630913 1986-12-24

Publications (1)

Publication Number Publication Date
KR880007084A true KR880007084A (ko) 1988-08-26

Family

ID=10609600

Family Applications (1)

Application Number Title Priority Date Filing Date
KR870014856A KR880007084A (ko) 1986-12-24 1987-12-24 제약 조성물

Country Status (13)

Country Link
US (1) US4985418A (ko)
EP (1) EP0278174B1 (ko)
JP (1) JPS63233998A (ko)
KR (1) KR880007084A (ko)
AT (1) ATE86491T1 (ko)
AU (1) AU8296987A (ko)
CA (1) CA1302262C (ko)
DE (1) DE3784693T2 (ko)
DK (1) DK678887A (ko)
ES (1) ES2053571T3 (ko)
GB (2) GB8630913D0 (ko)
NZ (1) NZ223045A (ko)
ZA (1) ZA879464B (ko)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5208226A (en) * 1989-09-08 1993-05-04 Glaxo Group Limited Medicaments
US5270305A (en) * 1989-09-08 1993-12-14 Glaxo Group Limited Medicaments
SE8903914D0 (sv) 1989-11-22 1989-11-22 Draco Ab Oral composition for the treatment of inflammatory bowel diseases
US5643602A (en) * 1989-11-22 1997-07-01 Astra Aktiebolag Oral composition for the treatment of inflammatory bowel disease
IT1256061B (it) * 1992-11-20 1995-11-23 Composizione terapeutica per uso rettale a base di flunisolide e/o deirelativi esteri per il trattamento di disordini intestinali a carattere infiammatorio
US6166024A (en) 1995-03-30 2000-12-26 Mayo Foundation For Medical Education And Research Use of topical azathioprine and thioguanine to treat colorectal adenomas
NL1006774C2 (nl) * 1996-08-14 1998-09-28 Univ Potchefstroom Anti-atherosclerose- en anti-trombotisch middel en het gebruik daarvan.
DE19732903A1 (de) 1997-07-30 1999-02-04 Falk Pharma Gmbh Pellet-Formulierung zur Behandlung des Intestinaltraktes
US5993782A (en) * 1998-04-28 1999-11-30 Gardner; Conrad O. Therapeutic method for reversing hyposmia in a human patient
AU3596199A (en) * 1998-05-06 1999-11-23 Kobenhavns Universitet Treatment of celiac disease
GB9823036D0 (en) * 1998-10-22 1998-12-16 Glaxo Group Ltd Fluticasone lotion having improved vasoconstrictor activity
US6667344B2 (en) 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
US20040023935A1 (en) * 2002-08-02 2004-02-05 Dey, L.P. Inhalation compositions, methods of use thereof, and process for preparation of same
US20040109826A1 (en) * 2002-12-06 2004-06-10 Dey, L.P. Stabilized albuterol compositions and method of preparation thereof
US20050009848A1 (en) * 2003-07-10 2005-01-13 Icn Pharmaceuticals Switzerland Ltd. Use of antivirals against inflammatory bowel diseases
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
US8497258B2 (en) * 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US8679545B2 (en) 2005-11-12 2014-03-25 The Regents Of The University Of California Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract
US8324192B2 (en) 2005-11-12 2012-12-04 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
EP3574914B1 (en) 2007-11-13 2021-12-29 ViroPharma Biologics LLC Corticosteroid compositions
US8865692B2 (en) * 2007-11-13 2014-10-21 Meritage Pharma, Inc Compositions for the treatment of gastrointestinal inflammation
US20100216754A1 (en) * 2007-11-13 2010-08-26 Meritage Pharma, Inc. Compositions for the treatment of inflammation of the gastrointestinal tract
MX2011003595A (es) 2008-10-03 2011-07-28 Falk Pharma Gmbh Composiciones y metodos para el tratamiento de enfermedades intestinales con mesalamina granulada.
EP2440210A4 (en) * 2009-06-12 2014-01-29 Meritage Pharma Inc METHOD FOR THE TREATMENT OF STOMACH DARM DISEASES
ES2683864T3 (es) 2009-10-01 2018-09-28 Adare Pharmaceuticals, Inc. Composiciones de corticosteroides administradas oralmente
WO2015034678A2 (en) 2013-09-06 2015-03-12 Aptalis Pharmatech, Inc. Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis
CA2936748C (en) 2014-10-31 2017-08-08 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
TWI728172B (zh) 2016-08-18 2021-05-21 美商愛戴爾製藥股份有限公司 治療嗜伊紅性食道炎之方法
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56138200A (en) * 1980-02-15 1981-10-28 Glaxo Group Ltd Androstane carbothioate compound
CY1291A (en) * 1980-02-15 1985-10-18 Glaxo Group Ltd Androstane 17 beta carbothioates
US4578221A (en) * 1980-04-23 1986-03-25 Glaxo Group Limited Androstane carbothioic acids
US4710495A (en) * 1980-07-10 1987-12-01 Otsuka Pharmaceutical Co., Ltd. Soft steroids having anti-inflammatory activity

Also Published As

Publication number Publication date
EP0278174A2 (en) 1988-08-17
CA1302262C (en) 1992-06-02
GB8729756D0 (en) 1988-02-03
ZA879464B (en) 1988-12-28
DE3784693T2 (de) 1993-06-17
EP0278174B1 (en) 1993-03-10
DK678887A (da) 1988-06-25
DK678887D0 (da) 1987-12-22
GB2199747A (en) 1988-07-20
NZ223045A (en) 1989-11-28
JPS63233998A (ja) 1988-09-29
ES2053571T3 (es) 1994-08-01
AU8296987A (en) 1988-06-30
DE3784693D1 (de) 1993-04-15
US4985418A (en) 1991-01-15
GB2199747B (en) 1990-10-24
GB8630913D0 (en) 1987-02-04
ATE86491T1 (de) 1993-03-15
EP0278174A3 (en) 1990-06-27

Similar Documents

Publication Publication Date Title
KR880007084A (ko) 제약 조성물
DK0502092T3 (da) Oralt præparat til behandling af inflammatoriske tarmsygdomme
DK349889A (da) Anvendelse af polyacrylater til fremstilling af et laegemiddel
KR970025615A (ko) 암 전이 억제제
DK324185D0 (da) 2-substituerede 1,3-propylidendiphosphonatderivater, deres fremstilling og farmaceutiske praeparater med indhold deraf
FI842457A0 (fi) 1-alkyl-androsta-1,4-dien-3,17-dioner, deras framstaellningsfoerfarande och dessa innehaollande farmaceutiska produkter.
ES2149733T1 (es) Composicion farmaceutica oral con liberacion modificada que contiene 5-asa y metodo para el tratamiento de enfermedades intestinales.
OA05980A (fr) Dispositif pour l'administration de substances médicamenteuses.
JPS536430A (en) Preparation of anticoagulant soft material for medical use
KR890003374A (ko) 정신 분열증 치료용 약제의 제조에 2-아미노-6-(트리플루오로메톡시)벤조티아졸의 이용
BE830577A (fr) Derives actifs d'acide acetique, compositions therapeutiques les contenant ainsi que les procedes de preparation de ces derives et compositions
SE7701263L (sv) Terapeutiska kompositioner och anvendning derav
BE876164A (fr) Medicament contre des maladies infectieuses des voies respiratoires
FR2311553A1 (fr) Medicament pour le traitement de la schizophrenie
FR2352814A1 (fr) Derives d'uracile, leur preparation et leur application en tant que medicaments
FR2422647A1 (fr) Nouvelles 2,4-diamino-5-benzylpyrimidines, leur preparation et leur application en tant que medicaments
NL7812403A (nl) Farmaceutisch preparaat voor de behandeling van diarree bij de mens.
JPS5432481A (en) Carbostyril derivatives
JPS536429A (en) Preparation of anticoagulating medical material
JPS5251032A (en) Medicines of disaccharide-glutathione derivatives
JPS52102431A (en) Remedies for mental disorder
FR2306689A1 (fr) Medicament pour le traitement de l'hyperlipemie, comprenant du l-ascorbate-2-sulfate de sodium
JPS5219929A (en) Processing unit to select names of diseases
KR900015747A (ko) 간장관련 질병 치료제의 제조방법
BE888325A (fr) Medicament pour activer le retablissement des handicapes mentaux.

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application